Jeppesen PB, et al. - A post-hoc analysis of phase 3 placebo-controlled study was performed to identify characteristics of patients in whom teduglutide has the largest effects on parenteral support volume response. The researchers associated reduced parenteral support volume with baseline parenteral support volume, bowel anatomy, and short bowel syndrome (SBS) features. These findings could inform initial parenteral support volume adjustments and management of these severely disabled patients.